Agency Information Collection Activities; Proposed Collection; Comments Requested; Extension With Change of a Previously Approved Collection: National Drug Threat Survey, 36582 [2013-14347]

Download as PDF 36582 Federal Register / Vol. 78, No. 117 / Tuesday, June 18, 2013 / Notices DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117–0052] Agency Information Collection Activities; Proposed Collection; Comments Requested; Extension With Change of a Previously Approved Collection: National Drug Threat Survey mstockstill on DSK4VPTVN1PROD with NOTICES ACTION: 30-Day Notice. The United States Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the Federal Register Volume 78, Number 64, page 20141 on April 3, 2013, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until July 18, 2013. This process is conducted in accordance with 5 CFR 1320.10. If you have comments especially on the estimated public burden and associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Richard L. Nagy, Unit Chief, Domestic Strategic Intelligence Unit, Office of Intelligence, Warning, Plans and Programs, Drug Enforcement Administration, 8701 Morrissette Drive, Springfield, VA 22152. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency whether the information will have practical utility; • Evaluate the accuracy of the agencies’ estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the VerDate Mar<15>2010 16:52 Jun 17, 2013 Jkt 229001 use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection 1117–0052 (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: National Drug Threat Survey. (3) Agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number: None. Component: Intelligence Division, Drug Enforcement Administration, U.S. Department of Justice. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Federal, State, Tribal, and Local, law enforcement agencies. Other: None. Abstract: This survey is a critical component of the National Drug Threat Assessment and other reports and assessments produced by the Drug Enforcement Administration. It provides direct access to detailed drug threat data from state and local law enforcement agencies. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that approximately 3,500 respondents will complete a survey response within approximately 20 minutes. (6) An estimate of the total public burden (in hours) associated with the collection: There are an estimated 1,167 total annual burden hours associated with this collection. If additional information is required contact: Jerri Murray, Department Clearance Officer, Policy and Planning Staff, Justice Management Division, Department of Justice, Two Constitution Square, 145 N Street NE., Suite 3W– 1407B, Washington, DC 20530. Dated: June 12, 2013. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2013–14347 Filed 6–17–13; 8:45 am] BILLING CODE 4410–09–P PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. 12–15] Belinda R. Mori, N.P.; Decision and Order On November 17, 2011, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, issued an Order to Show Cause to Belinda R. Mori, N.P. (Respondent), of Santa Fe, New Mexico. The Show Cause Order proposed the denial of Respondent’s pending application for a DEA Certificate of Registration, on the ground that her ‘‘registration would be inconsistent with the public interest.’’ ALJ Ex. 1, at 1. The Show Cause Order specifically alleged that on March 18, 2011, Respondent applied for a Certificate of Registration as a mid-level practitioner, seeking authority to dispense controlled substances in schedules II through V. Id. The Order further alleged that Respondent had previously held a registration, which authorized her to dispense controlled substances in schedules II through V as a mid-level practitioner but that ‘‘this registration expired on January 31, 2011.’’ Id. Next, the Show Cause Order alleged that ‘‘[b]etween August 29, 2009 and March 15, 2011, [Respondent] issued approximately thirty-three purported prescriptions for alprazolam (a [s]chedule IV controlled substance) to [her] daughter without conducting a medical examination and without creating a patient record,’’ and that these prescriptions ‘‘were issued outside the usual course of professional practice, in violation of Federal and . . . state law.’’ Id. (citing 21 CFR 1306.04(a); N.M Admin. Code tit. 16, §§ 12.2.7(V) and 12.2.13(N)(5)(g)). The Order further alleged that ‘‘[o]n or about March 15, 2011, [Respondent] issued a purported prescription for alprazolam . . . to [her] daughter . . . while [she was] without a valid DEA Certificate of Registration, in violation of Federal and . . . state law.’’ Id. at 2 (citing 21 U.S.C. 841(a)(1); N.M. Admin. Code tit. 16, § 12.2.13(N)(5)(a)). On December 5, 2011, Respondent, through her counsel, requested a hearing on the allegations. ALJ Ex. 2. The matter was placed on the docket of the Office of Administrative Law Judges (ALJ), and assigned to an ALJ who proceeded to conduct pre-hearing procedures. On December 20, 2011, the Government filed its pre-hearing statement. Therein, the Government provided notice that it intended to elicit E:\FR\FM\18JNN1.SGM 18JNN1

Agencies

[Federal Register Volume 78, Number 117 (Tuesday, June 18, 2013)]
[Notices]
[Page 36582]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-14347]



[[Page 36582]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[OMB Number 1117-0052]


Agency Information Collection Activities; Proposed Collection; 
Comments Requested; Extension With Change of a Previously Approved 
Collection: National Drug Threat Survey

ACTION: 30-Day Notice.

-----------------------------------------------------------------------

    The United States Department of Justice (DOJ), Drug Enforcement 
Administration (DEA), will be submitting the following information 
collection request to the Office of Management and Budget (OMB) for 
review and approval in accordance with the Paperwork Reduction Act of 
1995. The proposed information collection is published to obtain 
comments from the public and affected agencies. This proposed 
information collection was previously published in the Federal Register 
Volume 78, Number 64, page 20141 on April 3, 2013, allowing for a 60 
day comment period.
    The purpose of this notice is to allow for an additional 30 days 
for public comment until July 18, 2013. This process is conducted in 
accordance with 5 CFR 1320.10.
    If you have comments especially on the estimated public burden and 
associated response time, suggestions, or need a copy of the proposed 
information collection instrument with instructions or additional 
information, please contact Richard L. Nagy, Unit Chief, Domestic 
Strategic Intelligence Unit, Office of Intelligence, Warning, Plans and 
Programs, Drug Enforcement Administration, 8701 Morrissette Drive, 
Springfield, VA 22152.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:
     Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency 
whether the information will have practical utility;
     Evaluate the accuracy of the agencies' estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used;
     Enhance the quality, utility, and clarity of the 
information to be collected; and
     Minimize the burden of the collection of information on 
those who are to respond, including through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses.

Overview of This Information Collection 1117-0052

    (1) Type of Information Collection: Extension of a currently 
approved collection.
    (2) Title of the Form/Collection: National Drug Threat Survey.
    (3) Agency form number, if any, and the applicable component of the 
Department sponsoring the collection:
    Form number: None.
    Component: Intelligence Division, Drug Enforcement Administration, 
U.S. Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Primary: Federal, State, Tribal, and Local, law enforcement 
agencies.
    Other: None.
    Abstract: This survey is a critical component of the National Drug 
Threat Assessment and other reports and assessments produced by the 
Drug Enforcement Administration. It provides direct access to detailed 
drug threat data from state and local law enforcement agencies.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond: It is estimated 
that approximately 3,500 respondents will complete a survey response 
within approximately 20 minutes.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: There are an estimated 1,167 total annual burden 
hours associated with this collection.
    If additional information is required contact: Jerri Murray, 
Department Clearance Officer, Policy and Planning Staff, Justice 
Management Division, Department of Justice, Two Constitution Square, 
145 N Street NE., Suite 3W-1407B, Washington, DC 20530.

    Dated: June 12, 2013.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2013-14347 Filed 6-17-13; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.